Cargando…

Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities

The aim was to evaluate human papillomavirus (HPV) ‘reflex genotyping’ in cases of minor cytological abnormalities detected in the gynaecological screening programme in Stockholm, Sweden. Liquid-based cytology samples showing minor cytological abnormalities were analysed using HPV genotyping (Linear...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröberg, M, Johansson, B, Hjerpe, A, Andersson, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527833/
https://www.ncbi.nlm.nih.gov/pubmed/18682715
http://dx.doi.org/10.1038/sj.bjc.6604504
_version_ 1782158846077173760
author Fröberg, M
Johansson, B
Hjerpe, A
Andersson, S
author_facet Fröberg, M
Johansson, B
Hjerpe, A
Andersson, S
author_sort Fröberg, M
collection PubMed
description The aim was to evaluate human papillomavirus (HPV) ‘reflex genotyping’ in cases of minor cytological abnormalities detected in the gynaecological screening programme in Stockholm, Sweden. Liquid-based cytology samples showing minor cytological abnormalities were analysed using HPV genotyping (Linear Array, Roche diagnostics). Colposcopically directed cervical biopsies were obtained and the HPV test results were correlated with the histological results. In all, 63% (70/112) of the samples were high-risk (HR) HPV (HR-HPV) positive. A statistically significant correlation was found between high-grade cervical lesions and HR-HPV (P=0.019), among which HPV 16, 18, and 31 were the most important. The negative predictive value of HR-HPV detection for histologically confirmed high-grade lesions was 100%. An age limit for HPV reflex testing may be motivated in cases of low-grade squamous intraepithelial neoplasia (LSIL), because of high HR-HPV prevalence among younger women. By using HPV reflex genotyping, additional extensive workup can safely be avoided in about 50% of all cases of atypical squamous cells of undetermined significance (ASCUS) and LSIL among women ⩾30 years. This screening strategy could potentially reduce the total abnormal cytology-reporting rate in the Swedish screening programme by about 1% and provide more accurately directed follow-up, guided by cytological appearance and HPV test results.
format Text
id pubmed-2527833
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-25278332009-09-11 Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities Fröberg, M Johansson, B Hjerpe, A Andersson, S Br J Cancer Clinical Study The aim was to evaluate human papillomavirus (HPV) ‘reflex genotyping’ in cases of minor cytological abnormalities detected in the gynaecological screening programme in Stockholm, Sweden. Liquid-based cytology samples showing minor cytological abnormalities were analysed using HPV genotyping (Linear Array, Roche diagnostics). Colposcopically directed cervical biopsies were obtained and the HPV test results were correlated with the histological results. In all, 63% (70/112) of the samples were high-risk (HR) HPV (HR-HPV) positive. A statistically significant correlation was found between high-grade cervical lesions and HR-HPV (P=0.019), among which HPV 16, 18, and 31 were the most important. The negative predictive value of HR-HPV detection for histologically confirmed high-grade lesions was 100%. An age limit for HPV reflex testing may be motivated in cases of low-grade squamous intraepithelial neoplasia (LSIL), because of high HR-HPV prevalence among younger women. By using HPV reflex genotyping, additional extensive workup can safely be avoided in about 50% of all cases of atypical squamous cells of undetermined significance (ASCUS) and LSIL among women ⩾30 years. This screening strategy could potentially reduce the total abnormal cytology-reporting rate in the Swedish screening programme by about 1% and provide more accurately directed follow-up, guided by cytological appearance and HPV test results. Nature Publishing Group 2008-08-19 2008-08-05 /pmc/articles/PMC2527833/ /pubmed/18682715 http://dx.doi.org/10.1038/sj.bjc.6604504 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Fröberg, M
Johansson, B
Hjerpe, A
Andersson, S
Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
title Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
title_full Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
title_fullStr Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
title_full_unstemmed Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
title_short Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
title_sort human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527833/
https://www.ncbi.nlm.nih.gov/pubmed/18682715
http://dx.doi.org/10.1038/sj.bjc.6604504
work_keys_str_mv AT frobergm humanpapillomavirusreflextestingasascreeningmethodincasesofminorcytologicalabnormalities
AT johanssonb humanpapillomavirusreflextestingasascreeningmethodincasesofminorcytologicalabnormalities
AT hjerpea humanpapillomavirusreflextestingasascreeningmethodincasesofminorcytologicalabnormalities
AT anderssons humanpapillomavirusreflextestingasascreeningmethodincasesofminorcytologicalabnormalities